Devazepide
Devazepide is a potent, and orally active CCK1 (CCK-A) receptor antagonist that displays appetite-stimulant effects. It blocks the anorectic response to CCK-8 and increases food intake in rats following systemic and i.c.v administration.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD031 |
| CAS # | 103420-77-5 |
| Pricing | Customizable size, Inquiry |
| Synonym | Devazepide; Devazepide [USAN:INN]; L 364,718; L 364718; L-364,718; MK 329; MK-329; UNII-JE6P7QY7NH. |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C25H20N4O2 |
| Exact Mass | 408.15863 |
| Molecular Weight | 408.45 |
| Elemental Analysis | C, 73.51; H, 4.94; N, 13.72; O, 7.83 |
| IUPAC/Chemical Name | (S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide |
| InChi Key | NFHRQQKPEBFUJK-HSZRJFAPSA-N |
| InChi Code | InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1 |
| SMILES Code | CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c4ccccc4)c5ccccc15 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO, not in water |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |
| Availability | 2 Weeks |